We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been diagnosed with, or are you at risk for (diabetic or obese or have high blood pressure), nonalcoholic steatohepatitis (NASH)? If so, you may be eligible to participate in a study to help researchers find out whether an oral investigational medication, called Elafibranor, is safe and effective at treating and preventing disease progression and complications. Reimbursement provided.